Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Aceragen, Inc.
| Metric | Aceragen, Inc. Healthcare |
|---|---|
| Quality Score | 18 / 100 |
| Revenue (latest) | $5M |
| Net income (latest) | −$23M |
| Operating margin | −572.2% |
| Net margin | −480.5% |
| Return on equity | −197.5% |
| Return on assets | −23.1% |
| Return on capital (ROCE) | −34.9% |
| Debt / equity | 5.26× |
| Revenue growth (YoY) | — |
| Altman Z″ (distress) | -26.35 |
| Accruals / assets | 1.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.